Jade Thirlwall’s first solo performance at Capital’s Summertime Ball went off without a hitch but backstage things weren’t so smooth. With only three songs to play with, some cuts had to be ...

Best known for shaping the landscape of the British pop scene as one quarter of beloved girl group Little Mix, solo star Jade Thirlwall has proven that she's unafraid to take risks both musically ...

Jade Thirlwall kicked off the 2025 Capital Summertime Ball with Barclaycard at Wembley Stadium, making it her debut at the concert as a solo artist. However, it wasn’t Jade’s first time ...

Ladies and gentlemen, theys and thems, JADE has officially made her Summertime Ball debut as a solo artist. On top of that, she sang a medley of Little Mix's biggest hits bringing all 80,000 ...

The daughter of rapper Eminem, 29, dedicates a heartfelt post to her husband Evan McClintock on Instagram Hailie Jade/Instagram (2) This Father's Day was extra special for Evan McClintock and ...

Hailie Jade is losing herself in the joy of parenthood. After all, she’s had the perfect partner in husband Evan McClintock as the pair have navigated becoming mom and dad to 3-month-old son ...

Meteorologist Jade Steffens joined the First Alert 6 Weather team in June 2023. Jade started her career at KQTV in St. Joseph, Mo., where she spent two years covering morning and weekend shows ...

A popular content creator and sex worker has revealed her horrific experience after getting a Brazilian butt lift procedure in Turkey. Kayla Jade, who boasts 2.2 million followers on TikTok, said ...

This Father's Day was extra special for Evan McClintock and Hailie Jade Scott, as it marked their first together with their son, Elliot. The daughter of rapper Eminem, 29, took to Instagram to ...

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes ...

Last month Arcus reported top -line phase 2 results with the TIGIT drug that it said warranted taking it forward into a phase 3 programme, but so far there's no word from Gilead on a buy-in.

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...